{"id":"https://openalex.org/W2282994664","doi":null,"title":"Paliperidone in the treatment of Schizophrenia: An overview","display_name":"Paliperidone in the treatment of Schizophrenia: An overview","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2282994664","mag":"2282994664"},"language":"en","primary_location":{"id":"mag:2282994664","doi":null,"is_oa":false,"landing_page_url":"https://www.alliedacademies.org/articles/paliperidone-in-the-treatment-of-schizophrenia-an-overview.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764792516","display_name":"Current Neurobiology","issn_l":"0975-9042","issn":["0975-9042","0976-1705"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Current Neurobiology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009090023","display_name":"Anna Capasso","orcid":"https://orcid.org/0000-0002-6579-7802","observed_orcids":["https://orcid.org/0000-0002-6579-7802"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Capasso","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6579-7802","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113942471","display_name":"Walter Milano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter Milano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"3","issue":"2","first_page":"133","last_page":"150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paliperidone","display_name":"paliperidone","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8389999866485596},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9359999895095825},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonism","display_name":"dopamine D2 receptor antagonism","score":0.9070000052452087},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.9249105453491211},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8389142751693726},{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.8307597637176514},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7561817765235901},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6232004165649414},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5624186992645264},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5578516721725464},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.4946915805339813},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.46537157893180847},{"id":"https://openalex.org/C126855140","wikidata":"https://www.wikidata.org/wiki/Q14891424","display_name":"5-HT2A receptor","level":5,"score":0.4616573750972748},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.44986557960510254},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.35007476806640625},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.34479862451553345},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21475720405578613},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.1544097661972046},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1015295684337616}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2282994664","doi":null,"is_oa":false,"landing_page_url":"https://www.alliedacademies.org/articles/paliperidone-in-the-treatment-of-schizophrenia-an-overview.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764792516","display_name":"Current Neurobiology","issn_l":"0975-9042","issn":["0975-9042","0976-1705"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Current Neurobiology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W940697911","https://openalex.org/W1697211552","https://openalex.org/W2014631071","https://openalex.org/W2016880063","https://openalex.org/W2017912899","https://openalex.org/W2019907082","https://openalex.org/W2021230488","https://openalex.org/W2056039872","https://openalex.org/W2062573156","https://openalex.org/W2066213630","https://openalex.org/W2071090720","https://openalex.org/W2083269966","https://openalex.org/W2084120702","https://openalex.org/W2085602642","https://openalex.org/W2092841720","https://openalex.org/W2096775351","https://openalex.org/W2109865728","https://openalex.org/W2111883919","https://openalex.org/W2131658797","https://openalex.org/W2132980997","https://openalex.org/W2141834541","https://openalex.org/W2142151511","https://openalex.org/W2159155203","https://openalex.org/W2212027594"],"related_works":["https://openalex.org/W2016880063","https://openalex.org/W1965351344","https://openalex.org/W2041533856","https://openalex.org/W3214017741","https://openalex.org/W4250737441","https://openalex.org/W2937974660","https://openalex.org/W2131736555","https://openalex.org/W2495362657","https://openalex.org/W7125703872","https://openalex.org/W2069228787"],"abstract_inverted_index":{"The":[0,15,30,43],"schizophrenia":[1],"is":[2,69,110],"a":[3,21,72,87],"psychiatric":[4],"disease,":[5],"characterized":[6],"by":[7],"symptoms":[8],"alterating":[9],"the":[10,45,52,55,61,79,84,104,107,116,119,122],"mind,":[11],"behaviour":[12],"and":[13,18,41,60,64,76],"emotion.":[14],"terms":[16],"antipsychotic":[17],"neuroleptic":[19],"define":[20],"group":[22],"of":[23,48,57,91,106,118,121],"drugs":[24],"mainly":[25],"used":[26],"to":[27,101,112],"treat":[28],"schizophrenia.":[29],"antipsychotics":[31],"may":[32],"be":[33,99],"divided":[34],"into":[35],"two":[36],"classes:":[37],"classic":[38],"or":[39],"typical":[40],"atypical.":[42],"paliperidone,":[44],"major":[46],"metabolite":[47],"risperidone,":[49],"shares":[50],"with":[51,103],"native":[53],"drug":[54],"characteristics":[56],"receptorial":[58],"binding":[59],"serotonin":[62],"(5HT2A)":[63],"dopamine":[65],"(D2)":[66],"antagonism":[67],"Paliperidone":[68],"available":[70],"in":[71,115],"prolonged":[73],"release":[74],"formulation":[75],"it":[77],"allows":[78],"administration":[80],"once":[81],"daily.":[82],"Besides,":[83],"paliperidone":[85],"has":[86],"pharmacological":[88,96],"action":[89],"independent":[90],"CYT":[92],"P450,":[93],"thus,":[94],"several":[95],"interactions":[97],"would":[98],"avoided":[100],"interference":[102],"activity":[105],"CYP2D6,":[108],"that":[109],"known":[111],"have":[113],"involved":[114],"metabolism":[117],"25%":[120],"drugs.":[123]},"counts_by_year":[{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}